Fezolinetant (Veozah) for Perimenopause: A Complete Guide to the First Non-Hormonal Hot Flash Drug

Why Fezolinetant Feels Like a Breakthrough

Fezolinetant (brand name Veozah) is a medication approved by the FDA in 2023 for treating moderate-to-severe hot flashes and night sweats in perimenopause and menopause. Fezolinetant is a neurokinin-3 (NK3) receptor antagonist; it works in the brain to modulate thermoregulation (temperature regulation) through a different mechanism than HRT. Specifically, fezolinetant blocks NK3 receptors in the hypothalamus, reducing the perception of temperature drops that trigger hot flash sweating. This mechanism is completely different from estrogen replacement. The development of fezolinetant was significant because it provided a non-hormonal option for women unable or unwilling to use HRT. Fezolinetant is taken orally as a daily 45 mg tablet. In clinical trials, fezolinetant reduced moderate-to-severe hot flash frequency by 50-60 percent. Fezolinetant became available in 2024 in the US.

The Neurokinin B Pathway: Why Your Brain Triggers Hot Flashes

Fezolinetant provides a non-hormonal option for women with significant hot flashes and night sweats who prefer not to use HRT or who have contraindications to HRT (such as history of breast cancer, blood clots, or migraine with aura). Fezolinetant is not as effective as HRT for hot flashes (HRT reduces frequency 80-90 percent versus fezolinetant 50-60 percent), but it is significantly more effective than placebo. For women unable to use HRT, fezolinetant is a valuable option.

What the Clinical Trials Found

Discuss with your doctor whether fezolinetant is appropriate for you. It is prescribed medication, not available over-the-counter. Typical dose is 45 mg once daily taken orally. Take consistently every day for benefit (not as needed). Effects take 2-4 weeks to appear; allow full 4 weeks before assessing effectiveness. Continue for at least 3 months to determine if it is helping. Fezolinetant is relatively new; long-term safety data beyond 3 years is not yet available. Consider this when planning duration of use. Discuss with your doctor if you have liver disease, as fezolinetant is metabolized by the liver. Monitor for side effects: headache (14 percent of users), nausea (11 percent), diarrhea (8 percent), abdominal pain. Most side effects are mild and transient. Report any concerning side effects to your doctor immediately.

Who Fezolinetant Is Approved For

Hot flash frequency decreases 50-60 percent typically; some women experience greater reduction, others less. Night sweats similarly decrease 50-60 percent. Effects begin appearing within 2-3 weeks. Peak effect is around 4 weeks. If fezolinetant is not helping by 4 weeks, it is unlikely to be effective for you. Cognitive function does not improve as much as with HRT. Other perimenopause symptoms (mood, joint pain, vaginal dryness) do not improve; fezolinetant specifically targets thermoregulation.

Side Effects and What to Watch For

Do not assume fezolinetant will work as well as HRT; it is less effective. Do not give up after 1 week; effects take 4 weeks. Do not expect cognitive or mood improvement; fezolinetant is specific to hot flashes and night sweats. Do not use if you have serious liver disease.

Cost, Insurance, and Practical Access

See doctor if you develop severe side effects, if fezolinetant does not work by week 4, or if your hot flashes worsen despite fezolinetant.

Fezolinetant vs. HRT: How Do They Compare for Hot Flashes?

Patricia, 49, had severe hot flashes (15+ daily) and night sweats preventing sleep. She could not use HRT due to history of blood clots. She started fezolinetant 45 mg daily. By week 2, hot flashes decreased somewhat. By week 4, she averaged 6-7 hot flashes daily and was sleeping through the night 3-4 nights weekly. By week 8, she had further improvement. She continued fezolinetant with good results and substantially improved quality of life. David, 50, had significant night sweats waking him 4-5 times nightly. He started fezolinetant hoping to avoid HRT. By week 3, night sweats decreased to 1-2 awakenings. By week 4, he was waking only 1-2 nights weekly. He slept much better and continued fezolinetant long-term.

Finding a Provider Who Prescribes Veozah

Fezolinetant requires a prescription, and not all primary care providers are comfortable with it yet because it is still relatively new. Gynecologists and menopause specialists tend to be the most familiar with prescribing it. The Menopause Society (formerly NAMS) maintains a provider directory at menopause.org that lets you search for certified menopause practitioners in your area.

When you see your provider, it helps to come prepared with some specifics: how many hot flashes you are having per day, how they affect your sleep and daily functioning, and what you have already tried. Framing your symptoms in those concrete terms helps the provider understand why you want to explore this option and whether it fits your situation.

Some telehealth platforms that specialize in menopause care are also beginning to offer fezolinetant prescriptions. If in-person access is a challenge, that may be a route worth exploring. Regardless of how you access it, make sure whoever prescribes it has your full medication list, your liver function baseline, and a plan for the required follow-up monitoring.

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. Fezolinetant (Veozah) is a prescription medication that requires evaluation by a qualified healthcare provider. Every person's health history is different, and only your doctor can determine whether fezolinetant is appropriate for you. Do not start, stop, or change any medication without speaking to your healthcare provider first.

The information in this article reflects research and prescribing information available as of early 2026 and may not reflect the most current clinical guidance.